Dr. Robert Jenkins, M.D., PHD.
What this data tells you about Dr. Jenkins
Dr. Robert Jenkins is a rheumatology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jenkins performed 69,653 Medicare services across 3,425 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jenkins received a total of $76,778 from 37 pharmaceutical and/or device companies across 743 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jenkins is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 61,000 | $4 | $15 |
| Denosumab injection (Prolia/Xgeva) | 1,920 | $18 | $69 |
| Comprehensive metabolic blood panel | 884 | $10 | $32 |
| Complete blood count (CBC) with differential | 882 | $7 | $23 |
| Blood draw (venipuncture) | 873 | $8 | $27 |
| C-reactive protein test (inflammation marker) | 871 | $5 | $16 |
| Sed rate test (inflammation marker) | 862 | $3 | $8 |
| Office visit, established patient (30-39 min) | 858 | $90 | $378 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 376 | $58 | $218 |
| Vitamin D level test | 106 | $29 | $89 |
| Automated urinalysis | 100 | $2 | $7 |
| Uric acid level test | 99 | $4 | $14 |
| Urinalysis with microscopic exam | 93 | $3 | $10 |
| Measurement of complement (immune system proteins), antigen, | 72 | $11 | $36 |
| Creatine kinase (cardiac enzyme) level, total | 63 | $6 | $20 |
| Office visit, established patient (20-29 min) | 58 | $63 | $267 |
| Measurement of antibody for rheumatoid arthritis assessment | 56 | $12 | $39 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 55 | $17 | $54 |
| Rheumatoid factor level | 54 | $5 | $17 |
| Screening test for autoimmune disorder | 53 | $11 | $36 |
| Drug screening test | 49 | $59 | $186 |
| Screening test for antibody to noninfectious agent | 36 | $11 | $36 |
| New patient office visit (45-59 min) | 31 | $105 | $491 |
| New patient office visit, complex (60-74 min) | 31 | $165 | $648 |
| Lipid panel (cholesterol and triglycerides) | 18 | $13 | $40 |
| Office visit, established patient, complex (40-54 min) | 17 | $134 | $530 |
| Hepatitis c antibody measurement | 15 | $14 | $43 |
| Thyroid stimulating hormone (TSH) test | 14 | $16 | $50 |
| Joint injection, major joint | 13 | $54 | $191 |
| Flu vaccine administration | 13 | $31 | $80 |
| Hepatitis b core antibody measurement | 12 | $12 | $36 |
| Hepatitis b surface antibody measurement | 12 | $11 | $32 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 12 | $10 | $31 |
| Flu vaccine, high-dose | 12 | $71 | $587 |
| Blood viscosity measurement | 11 | $11 | $35 |
| Body fluid cell count with cell identification | 11 | $5 | $17 |
| Crystal identification from tissue or body fluid | 11 | $7 | $22 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for rheumatology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jenkins is a mixed practice specialist, with above-average Medicare volume (top 19% in TX), with speaking/promotional industry engagement in the top 8% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jenkins experienced with certolizumab injection (cimzia)?
Does Dr. Jenkins receive payments from pharmaceutical companies?
How do Dr. Jenkins's costs compare to other rheumatologists in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology